Clinical Trial Update: Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol [Phase 3]

View source ↗

Summary

A Phase 3 trial combining Dienogest/Ethynilestradiol and Drospirenone/Ethynilestradiol for metrorrhagia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metrorrhagia

Drugs mentioned

• Dienogest/Ethynilestradiol (Dienogest/Ethynilestradiol)
• Drospirenone/Ethynilestradiol (Drospirenone/Ethynilestradiol)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Metrorrhagia | Phase 3 | Status: WITHDRAWN